Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy R1 RCM stock in Canada | $23.15

Own R1 RCM shares in just a few minutes.

R1 RCM Inc
+$0.20 (+0.97%)

R1 RCM is a health information services business based in the US. R1 RCM stocks (RCM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $22.3 – a decrease of 8.89% over the previous week. R1 RCM employs 19,000 staff and has a trailing 12-month revenue of around $1.3 billion.

How to buy R1 RCM stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: RCM in this case.
  5. Research R1 RCM stocks. The platform should provide the latest information available.
  6. Buy your R1 RCM stocks. It's that simple.

How has Coronavirus impacted R1 RCM's stock price?

Since the stock market crash in March caused by coronavirus, R1 RCM's stock price has had significant positive movement.

Its last market close was $23.15, which is 39.91% up on its pre-crash value of $13.91 and 225.14% up on the lowest point reached during the March crash when the stocks fell as low as $7.12.

If you had bought $1,000 worth of R1 RCM stocks at the start of February 2020, those stocks would have been worth $694.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,840.19.

R1 RCM stock price

Use our graph to track the performance of RCM stocks over time.

R1 RCM stocks at a glance

Information last updated 2021-07-22.
Latest market close$23.15
52-week range$13.21 - $31.28
50-day moving average $21.8503
200-day moving average $24.8653
Wall St. target price$33.57
Dividend yield N/A (0%)
Earnings per share (TTM) $0.327

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Is it a good time to buy R1 RCM stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

R1 RCM price performance over time

Historical closes compared with the last close of $23.15

1 month (2021-06-25) 2.21%
3 months (2021-04-26) -14.20%

Is R1 RCM under- or over-valued?

Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

R1 RCM's PEG ratio

R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3902. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.


R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$223.1 million.

The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.

R1 RCM financials

Revenue TTM USD$1.3 billion
Operating margin TTM 11.77%
Gross profit TTM USD$249.7 million
Return on assets TTM 9.16%
Return on equity TTM 45.38%
Profit margin 9.65%
Book value $1.085
Market capitalisation USD$5.7 billion

TTM: trailing 12 months

How to short and sell R1 RCM stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "RCM.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 4.8 million R1 RCM stocks held short by investors – that's known as R1 RCM's "short interest". This figure is 3.9% up from 4.7 million last month.

There are a few different ways that this level of interest in shorting R1 RCM stocks can be evaluated.

R1 RCM's "short interest ratio" (SIR)

R1 RCM's "short interest ratio" (SIR) is the quantity of R1 RCM stocks currently shorted divided by the average quantity of R1 RCM stocks traded daily (recently around 1.7 million). R1 RCM's SIR currently stands at 2.79. In other words for every 100,000 R1 RCM stocks traded daily on the market, roughly 2790 stocks are currently held short.

However R1 RCM's short interest can also be evaluated against the total number of R1 RCM stocks, or, against the total number of tradable R1 RCM stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case R1 RCM's short interest could be expressed as 0.02% of the outstanding stocks (for every 100,000 R1 RCM stocks in existence, roughly 20 stocks are currently held short) or 0.0383% of the tradable stocks (for every 100,000 tradable R1 RCM stocks, roughly 38 stocks are currently held short).

Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against R1 RCM.

Find out more about how you can short R1 RCM stock.

R1 RCM stock dividends

We're not expecting R1 RCM to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

R1 RCM stock price volatility

Over the last 12 months, R1 RCM's stocks have ranged in value from as little as $13.21 up to $31.28. A popular way to gauge a stock's volatility is its "beta".

RCM.US volatility(beta: 0.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.8172. This would suggest that R1 RCM's stocks are less volatile than average (for this exchange).

R1 RCM overview

R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site